The contribution of PRL and the PRL receptor (PRLR) to BC etiology and progression is overall associated with invasive behavior [99], poor prognosis [100], increased BC cell survival [101], DNA damage resistance [102], and the induction of lytic bone metastases [103]. This evidence concerns the gene PRLR and breast cancer.